text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 71-58-9 | Product Number: M1964

Medroxyprogesterone Acetate


Purity: >93.0%(GC)
Synonyms:
  • Medroxyprogesterone 17-Acetate
  • 17α-Acetoxy-6α-methylprogesterone
  • 17α-Hydroxy-6α-methyl-4-pregnene-3,20-dione 17-Acetate
Product Documents:
1G
€ 38,00
1   10  
5G
€ 124,00
3   ≥100 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number M1964
Purity / Analysis Method >93.0%(GC)
Molecular Formula / Molecular Weight C__2__4H__3__4O__4 = 386.53 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
CAS RN 71-58-9
Reaxys Registry Number 2066112
PubChem Substance ID 87560200
MDL Number

MFCD00010483

Specifications
Appearance White to Almost white powder to crystal
Purity(GC) min. 93.0 %
Melting point 203.0 to 209.0 °C
Specific rotation [a]20/D +45.0 to +51.0 deg(C=1, Dioxane)
Properties (reference)
Melting Point 206 °C
Specific Rotation 48° (C=1,Dioxane)
Solubility in water Insoluble
Solubility (soluble in) Dimethylformamide
Solubility (slightly sol. in) Alcohol
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H351 : Suspected of causing cancer.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P202 : Do not handle until all safety precautions have been read and understood.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
P405 : Store locked up.
Related Laws:
EC Number 200-757-9
RTECS# TU5010000
Transport Information:
HS Number 2937290000
Application
Medroxyprogesterone acetate: Semi-Synthetic Progestational Agent

Medroxyprogesterone acetate (MPA) and megestrol acetate [M1949], semi-synthetic progestational agents, are effective hormonal treatments for metastatic breast cancer in postmenopausal women. The antineoplastic effect may result from inhibition of pituitary gonadotropin production and resultant decrease in estrogen secretion. In addition, MPA has the pregnancy maintaining effect and the anti-estrogen effect. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.